Morgan Stanley & Co. LLC
1585 Broadway
New York, New York 10036
January 24, 2020
VIA EDGAR
Securities and Exchange Commission
Division of Investment Management
100 F Street, N.E.
Washington, D.C. 20549
| Attn.: | Deborah L. O’Neal |
Attorney, Disclosure Review Office
BlackRock Health Sciences Trust II
Registration Statement on FormN-2
File Nos.333-233373;811-23466
Dear Ms. O’Neal:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned, as representative of the prospective underwriters of the securities covered by the above-captioned Registration Statement, hereby joins in the request of BlackRock Health Sciences Trust II that the effectiveness of the Registration Statement relating to such securities be accelerated so that the Registration Statement will become effective by 12:00 pm, Eastern Time, on January 28, 2020, or as soon thereafter as practicable.
[Signature Page Follows]
Sincerely, | ||
| MORGAN STANLEY & CO. LLC | ||
As Representative of the several Underwriters | ||
By: | /s/ Celestina Milner | |
Name: | Celestina Milner | |
Title: | Executive Director | |
